Significant ALDH3A1 upregulation in HCC and hepatocellular adenomas serves as a biomarker of Wnt/β-catenin signaling pathway activation, although no correlation has been found between ALDH3A1 expression and patient prognosis.165, 166. Here, ALDH3A1 is linked to hepatocellular carcinoma.